Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,636 | 91 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $185.35 | 13 | $0 (2023) |
| Novo Nordisk Inc | $178.78 | 12 | $0 (2023) |
| Amgen Inc. | $177.51 | 5 | $0 (2023) |
| GlaxoSmithKline, LLC. | $145.29 | 10 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $134.05 | 5 | $0 (2022) |
| PFIZER INC. | $109.07 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $85.28 | 5 | $0 (2024) |
| ABBVIE INC. | $63.41 | 3 | $0 (2023) |
| Dexcom, Inc. | $60.53 | 4 | $0 (2023) |
| Astellas Pharma US Inc | $58.60 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34.01 | 2 | Novartis Pharmaceuticals Corporation ($34.01) |
| 2023 | $692.42 | 39 | Novo Nordisk Inc ($81.13) |
| 2022 | $424.56 | 22 | Amgen Inc. ($129.53) |
| 2021 | $372.73 | 21 | AstraZeneca Pharmaceuticals LP ($105.50) |
| 2020 | $77.84 | 5 | PFIZER INC. ($41.67) |
| 2019 | $34.69 | 2 | Otsuka America Pharmaceutical, Inc. ($20.41) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/14/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/16/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Bone Health | ||||||
| 11/14/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Obesity | ||||||
| 11/02/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Diabetes | ||||||
| 10/26/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/25/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: PAIN | ||||||
| 10/19/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Biological | ||||||
| 10/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/26/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Obesity | ||||||
| 09/22/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/14/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/08/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/07/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Neuroscience | ||||||
| 08/31/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.31 | General |
| 08/24/2023 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUZONE QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Vaccines | ||||||
| 08/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: RESPIRATORY | ||||||
| 06/30/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/27/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Endocrinology | ||||||
| 06/20/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Neuroscience | ||||||
| 06/13/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 532 | 747 | $113,582 | $46,712 |
| 2022 | 6 | 425 | 525 | $84,690 | $51,166 |
| 2021 | 4 | 93 | 106 | $17,323 | $11,512 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 142 | 142 | $35,122 | $15,745 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 234 | $29,493 | $13,226 | 44.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 196 | $16,712 | $7,824 | 46.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 28 | 38 | $13,841 | $3,516 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 38 | $6,779 | $2,903 | 42.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 49 | $4,151 | $1,727 | 41.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 30 | $6,870 | $1,663 | 24.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 19 | 20 | $614.00 | $108.11 | 17.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 128 | 168 | $28,536 | $20,175 | 70.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 180 | $21,815 | $14,202 | 65.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 71 | 71 | $17,052 | $8,889 | 52.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 17 | 21 | $7,389 | $3,256 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 63 | $5,350 | $3,146 | 58.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $4,548 | $1,497 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 51 | $5,943 | $4,686 | 78.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 24 | 24 | $5,634 | $3,072 | 54.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 16 | $2,656 | $2,048 | 77.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $3,090 | $1,706 | 55.2% |
About Michael Lane
Michael Lane is a Family Medicine healthcare provider based in Bay City, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2018. The National Provider Identifier (NPI) number assigned to this provider is 1073007159.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Lane has received a total of $1,636 in payments from pharmaceutical and medical device companies, with $34.01 received in 2024. These payments were reported across 91 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,636).
As a Medicare-enrolled provider, Lane has provided services to 1,050 Medicare beneficiaries, totaling 1,378 services with total Medicare billing of $109,390. Data is available for 3 years (2021–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bay City, MI
- Active Since 06/21/2018
- Last Updated 05/23/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1073007159
Products in Payments
- TRELEGY ELLIPTA (Drug) $145.29
- Repatha (Biological) $115.00
- EMGALITY (Drug) $98.44
- ELIQUIS (Drug) $91.16
- ENTRESTO (Drug) $85.28
- FARXIGA (Drug) $79.86
- EVENITY (Biological) $62.51
- TRULICITY (Drug) $57.86
- Auvelity (Drug) $57.79
- BREZTRI (Drug) $54.19
- Saxenda (Drug) $49.86
- NURTEC ODT (Drug) $42.04
- VRAYLAR (Drug) $40.82
- SPRAVATO (Drug) $39.17
- Kerendia (Drug) $37.06
- Wegovy (Drug) $32.69
- DEXCOM G6 TRANSMITTER (Device) $31.79
- JARDIANCE (Drug) $30.53
- Senza (Device) $29.86
- MOUNJARO (Drug) $29.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bay City
Dr. James Campau, D.o, D.O
Family Medicine — Payments: $44,438
Andrew Whiteside, Do, DO
Family Medicine — Payments: $10,130
Dr. Janet Guisinger, M.d, M.D
Family Medicine — Payments: $10,124
Michael Neret, Md, MD
Family Medicine — Payments: $5,194
Nicholas Orow, M.d, M.D
Family Medicine — Payments: $4,739
Dr. Charles Kerr, D.o, D.O
Family Medicine — Payments: $4,170